Montanaro, M.; Agostini, M.; Anemona, L.; Bonanno, E.; Servadei, F.; Finazzi Agrò, E.; Asimakopoulos, A.D.; Ganini, C.; Cipriani, C.; Signoretti, M.;
et al. ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. Int. J. Mol. Sci. 2023, 24, 6519.
https://doi.org/10.3390/ijms24076519
AMA Style
Montanaro M, Agostini M, Anemona L, Bonanno E, Servadei F, Finazzi Agrò E, Asimakopoulos AD, Ganini C, Cipriani C, Signoretti M,
et al. ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. International Journal of Molecular Sciences. 2023; 24(7):6519.
https://doi.org/10.3390/ijms24076519
Chicago/Turabian Style
Montanaro, Manuela, Massimiliano Agostini, Lucia Anemona, Elena Bonanno, Francesca Servadei, Enrico Finazzi Agrò, Anastasios D. Asimakopoulos, Carlo Ganini, Chiara Cipriani, Marta Signoretti,
and et al. 2023. "ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer" International Journal of Molecular Sciences 24, no. 7: 6519.
https://doi.org/10.3390/ijms24076519
APA Style
Montanaro, M., Agostini, M., Anemona, L., Bonanno, E., Servadei, F., Finazzi Agrò, E., Asimakopoulos, A. D., Ganini, C., Cipriani, C., Signoretti, M., Bove, P., Rugolo, F., Imperiali, B., Melino, G., Mauriello, A., & Scimeca, M.
(2023). ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. International Journal of Molecular Sciences, 24(7), 6519.
https://doi.org/10.3390/ijms24076519